These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24228554)

  • 21. Understanding and managing the adverse effects of antiretroviral therapy.
    Hawkins T
    Antiviral Res; 2010 Jan; 85(1):201-9. PubMed ID: 19857521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk among HIV-positive patients on antiretroviral therapy.
    Aberg JA
    J Int Assoc Physicians AIDS Care (Chic); 2003 Sep; 2 Suppl 2():S24-39. PubMed ID: 14569635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selected metabolic and morphologic complications associated with highly active antiretroviral therapy.
    Smith KY
    J Infect Dis; 2002 May; 185 Suppl 2():S123-7. PubMed ID: 12001033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of lipid-lowering agents in HIV-infected patients.
    Meienberg F; Battegay E; Bucher HC; Battegay M
    J HIV Ther; 2001 May; 6(2):40-4. PubMed ID: 11501203
    [No Abstract]   [Full Text] [Related]  

  • 26. High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection.
    Sabundayo BP; McArthur JH; Langan SJ; Gallant JE; Margolick JB
    Pharmacotherapy; 2006 May; 26(5):674-81. PubMed ID: 16637796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients.
    Kong HH; Myers SA
    Dermatol Ther; 2005; 18(1):58-66. PubMed ID: 15842613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.
    Bonnet F; Balestre E; Thiébaut R; Mercié P; Dupon M; Morlat P; Dabis F;
    HIV Med; 2004 May; 5(3):133-9. PubMed ID: 15139977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy.
    Auerbach E; Aboulafia DM
    Semin Thromb Hemost; 2012 Nov; 38(8):830-8. PubMed ID: 23041980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.
    Dubé MP; Stein JH; Aberg JA; Fichtenbaum CJ; Gerber JG; Tashima KT; Henry WK; Currier JS; Sprecher D; Glesby MJ; ;
    Clin Infect Dis; 2003 Sep; 37(5):613-27. PubMed ID: 12942391
    [No Abstract]   [Full Text] [Related]  

  • 32. Popular use of traditional Chinese medicine in HIV patients in the HAART era.
    Ma K; Lee SS; Chu EK; Tam DK; Kwong VS; Ho CF; Cheng K; Wong KH
    AIDS Behav; 2008 Jul; 12(4):637-42. PubMed ID: 17492500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
    Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
    Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
    Blanes M; Belinchón I; Portilla J
    Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperlipidemia in children with HIV infection: an emerging problem.
    Kamin D; Hadigan C
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):143-50. PubMed ID: 15030304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances of research on anti-HIV agents from traditional Chinese herbs.
    Chu Y; Liu H
    Adv Dent Res; 2011 Apr; 23(1):67-75. PubMed ID: 21441484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
    Burgoyne RW; Tan DH
    J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges.
    Liu ZB; Wang X; Liu HJ; Jin YT; Guo HJ; Jiang ZQ; Li Z; Xu LR
    Chin J Integr Med; 2013 Aug; 19(8):563-7. PubMed ID: 23893134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.